Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches
Vinit Raj, Jae Gyu Park, Kiu-Hyung Cho, Pilju Choi, Taejung Kim, Jungyeob Ham, Jintae Lee
Topics & Concepts
CannabidiolIn silicoVirtual screeningCoronavirusCannabinolIn vitroIC50Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PharmacologyDrugDrug discoveryLopinavirNitazoxanideIn vivoChemistryCoronavirus disease 2019 (COVID-19)VirologyBiologyMedicineVirusViral loadBiochemistryImmunologyCannabisGeneInfectious disease (medical specialty)DiseaseBiotechnologyPsychiatryAntiretroviral therapyPathologyCannabis and Cannabinoid ResearchPharmacological Receptor Mechanisms and EffectsSARS-CoV-2 and COVID-19 Research